Anti-HER2×CCR4 Bispecific Antibody Enhances Antitumor Immunity in Advanced HER2-Positive Tumors by Chemotaxis Blockade and Depletion of Tumor-Associated Tregs, Without Inducing Systemic Toxicity
杂志期刊:Journal for Immuno Therapy of Cancer
影响因子:10.6
客户单位:南开大学药学院
助力服务:PBMC, CD8+T细胞,CD4+T细胞,CD34+ HSC细胞分离服务